Page last updated: 2024-09-04

n-hydroxysulfosuccinimide and maleimide

n-hydroxysulfosuccinimide has been researched along with maleimide in 1 studies

Compound Research Comparison

Studies
(n-hydroxysulfosuccinimide)
Trials
(n-hydroxysulfosuccinimide)
Recent Studies (post-2010)
(n-hydroxysulfosuccinimide)
Studies
(maleimide)
Trials
(maleimide)
Recent Studies (post-2010) (maleimide)
300137932487

Protein Interaction Comparison

ProteinTaxonomyn-hydroxysulfosuccinimide (IC50)maleimide (IC50)
[tau protein] kinase Oryctolagus cuniculus (rabbit)6
Glycogen synthase kinase-3 alphaHomo sapiens (human)6
Glycogen synthase kinase-3 betaHomo sapiens (human)6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J; Li, X; Li, Y; Liu, W; Mu, H; Sun, K; Wang, A; Wang, M; Wu, Z; Zhang, X1

Other Studies

1 other study(ies) available for n-hydroxysulfosuccinimide and maleimide

ArticleYear
Synthesis of a bi-functional dendrimer-based nanovehicle co-modified with RGDyC and TAT peptides for neovascular targeting and penetration.
    International journal of pharmaceutics, 2016, Mar-30, Volume: 501, Issue:1-2

    Topics: Animals; Cell Line, Tumor; Cell Survival; Cell-Penetrating Peptides; Cells, Cultured; Dendrimers; Female; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Maleimides; Mice, Inbred BALB C; Mice, Nude; Nanostructures; Neoplasms; Neovascularization, Pathologic; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Polyethylene Glycols; Succinimides; tat Gene Products, Human Immunodeficiency Virus

2016